Advertisement

Lifelines pp 59-68 | Cite as

Pharmacotherapy of the Suicidal Patient

  • Stephen C. Schoonover

Abstract

Medication is frequently an adjunct to crisis therapies and initially may be the primary treatment method. The choice of a regimen depends on the identification of a drug-responsive syndrome (see Chart I) and on the evaluation of possible risks from medical conditions, side effects, potential abuse, and other medications. If suicidal symptoms interfere with adequate cooperation in psychotherapy the clinician should administer medication early in treatment. Intense confusion, feelings of helplessness and despair, and preoccupation with internal cues may predominate the patient’s awareness, particularly in individuals with major affective disorders or schizophrenialike psychoses. These characteristics may significantly limit the usefulness of ego supportive approaches, that encourage cooperation and rapport with the clinician, reestablishment of previously effective social attachments, and the mobilization of cognitive defenses. Frequently, patients with affective and psychotic disorders improve only after therapeutic doses of medication are administered for several weeks. The sedative, antianxiety, and neuroleptic properties of antipsychotic agents and the cyclic antidepressants, however, provide more immediate relief.

Keywords

Antipsychotic Agent Suicidal Patient Major Affective Disorder Severe Central Nervous System Cyclic Antidepressant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    DSM III—Diagnostic and Statistical Manual of Mental Disorders, The American Psychiatric Association, Washington, DC, 1980Google Scholar
  2. 2.
    Donlon P, Hopkin J, Tupin J: Overview: efficacy and safety of the rapid neuroleptization methods with injectable haloperidol. Am J Psych 136:273–279, 1979Google Scholar
  3. 3.
    Rosen H: A Clinician’s Guide to Affective Disorders. Miami, Mnemosyne Publishing Company, 1981Google Scholar
  4. 4.
    Bassuk E, Schoonover S: The Practitioner’s Guide to Psychoactive Drugs. New York, Plenum Press, 1977Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Stephen C. Schoonover
    • 1
  1. 1.Harvard Medical SchoolUSA

Personalised recommendations